Investment Analysts' Recent Ratings Changes for Bristol-Myers Squibb (BMY)

Several brokerages have updated their recommendations and price targets on shares of Bristol-Myers Squibb (NYSE: BMY) in the last few weeks: 6/6/2022 – Bristol-Myers Squibb had its price target raised by analysts at Bank of America Co. from $78.00 to $80.00. They now have a “buy” rating on the stock. 6/3/2022 – Bristol-Myers Squibb was […]

Related Keywords

Wellington ,New Zealand General ,New Zealand ,United States ,America ,Pomalyst Imnovid ,Rupert Vessey ,Raymond James ,Bristol Myers Squibb ,Sandra Leung ,Geode Capital Management ,Norges Bank ,Wellington Management Group ,Bristol Myers Squibb Company ,Capital International Investors ,Wells Fargo Company ,Truist Financial Co ,America Co ,Barclays Plc ,Citigroup Inc ,Wells Fargo ,Truist Financial ,Myers Squibb ,Get Rating ,Street Corp ,Management Group ,Capital Management ,International Investors ,Myers Squibb Company ,Nyse Bmy ,Bmy ,